China-Biotics, Inc, CHBT Securities Stock Fraud

Company:	China-Biotics, Inc,
Ticker Symbol:	CHBT
Class Period:	Feb-9-11 to Jul-1-11
Date Filed:	May-25-12
Lead Plaintiff Deadline:	Jul-24-12
Court:	Southern District of New York
Allegations:

New York, NY: A securities class action has been commenced on behalf of an investor in the United States District Court for the Southern District of New York on behalf of purchasers of the common stock of China-Biotics, Inc. ("China-Biotics" or the "Company") between February 9, 2011 and July 1, 2011, inclusive (the "Class Period"), seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act").

The complaint alleges that, during the Class Period, Defendants knew, or recklessly disregarded, that the Company fabricated (i) a false sales contract; (ii) a false bank website; and (iii) a false bank advice in furtherance of its scheme to fraudulently create the appearance of having achieved a 50% growth in 2011 revenue. As a result of the dissemination of the materially false and misleading information and failure to disclose material facts, the market price of China-Biotics common stock was artificially inflated during the Class Period.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

China-Biotics, Inc, CHBT Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible China-Biotics, Inc, securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.
Published on May-28-12